Friday, July 10, 2026

pharma · Elderly AML Patients · Menkes Syndrome

Kunming Hope of

Kunming Hope of clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
8
Patents
0
Intelligence · Clinical Programs

Kunming Hope of projects

1 ClinicalTrials.gov programs sponsored by Kunming Hope of.

Kunming Hope of has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Experimental: Venetoclax in combination with Decitabine (+-sorafenib)

    Kunming Hope of Health Hospital

    Elderly AML Patients

    phase 3 other active

    1 trial

Frequently asked questions

How many clinical projects does Kunming Hope of have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.